Health
COVID-19 Testing Stocks Move Lower After Abbott Receives EUA For 15-Minute Test – Benzinga
Abbott Laboratories (NYSE: ABT) announced late Wednesday the receipt of emergency use authorization from the FDA for its $5, 15-minute COVID-19 antigen …
Abbott Laboratories (NYSE: ABT) announced late Wednesday the receipt of emergency use authorization from the FDA for its $5, 15-minute COVID-19 antigen test.
Abbott’s BinaxNOW could be transformative, Morgan Stanley analyst David Lewis said in a note.
The test is bigger and better than expected, given the $5 price point; the fact that it’s a nasal swab; its better-than-expected performance; and a higher shipment volume, the analyst said.
The Sympathy Move: The announcement, though catalyzing…
-
General17 hours agoSearch underway for missing boat off South Australia’s Cape Jaffa
-
Noosa News18 hours agoQueensland coroner investigates ‘extremely unusual’ deaths of premature twin boys
-
General20 hours agoReuven Morrison was killed in the Bondi Beach shooting one year after warning about antisemitism
-
Noosa News21 hours agoSpectacular Sunset Carols | Noosa Today